Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients.
about
Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up StudiesBenznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatmentsChanges in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy.Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' diseaseScreening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies.Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian AdultsSerological evaluation of specific-antibody levels in patients treated for chronic Chagas' diseaseSequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult PatientsTowards a paradigm shift in the treatment of chronic Chagas disease.A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention.Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease.Experimental and Clinical Treatment of Chagas Disease: A Review.Genotyping of Trypanosoma cruzi sublineage in human samples from a North-East Argentina area by hybridization with DNA probes and specific polymerase chain reaction (PCR).The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America
P2860
Q26782118-A5133048-BCEF-419E-AA9E-8855693C9103Q28535357-AF15002B-96D8-435D-9323-427B41BD3B41Q33585491-D845B64D-46CE-40F2-8472-F4347611339FQ33870409-B03B1E19-36A4-4951-87EF-B7DCB9016A00Q33918063-9354938E-D9BA-46E6-AB43-285EA7384D12Q34549703-47ED059E-3E45-4F6F-9D12-7CC47CE9DA4BQ36359270-FEBEE880-36DF-4147-9491-98840E091994Q36452383-E3882741-7C46-489C-9388-75ACB9739D2CQ36526649-B7C1022C-E06A-42E5-9062-24AD7E9044E3Q36571807-E94A2520-1A31-40BE-B6EE-5B429D6A408CQ37544885-A63C2A76-968F-4DCE-92EA-AE605AED2625Q37675152-19918098-3436-4DCC-8315-AE8390E8D0F2Q40290159-A8062024-8CF9-4FB1-B338-9501E38D5AABQ41890035-205BC421-22ED-4C1F-B3AD-A9EB0494D5A6Q41989175-5F10BEF6-823A-4376-8D78-BFD08696C553Q42941204-35C41926-FCD6-496B-B94B-41EF248E2E00Q58571928-179720C5-2B6F-4938-910D-A7470716362B
P2860
Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Evolutive behavior towards car ...... ted chronic chagasic patients.
@en
Evolutive behavior towards cardiomyopathy of treated
@nl
type
label
Evolutive behavior towards car ...... ted chronic chagasic patients.
@en
Evolutive behavior towards cardiomyopathy of treated
@nl
prefLabel
Evolutive behavior towards car ...... ted chronic chagasic patients.
@en
Evolutive behavior towards cardiomyopathy of treated
@nl
P2093
P1476
Evolutive behavior towards car ...... ted chronic chagasic patients.
@en
P2093
Del Barco M
Fabbro De Suasnábar D
Ingaramo M
Piacenza M
Streiger M
P304
P577
2000-03-01T00:00:00Z